Back to RecallTracker
Health Canada Health products

EVUSHELD (tixagevimab and cilgavimab for injection) - Risk of Prophylaxis or Treatment Failure due to Antiviral Resistance

Issued October 26, 2022
Issue
EVUSHELD (tixagevimab and cilgavimab for injection) may not be effective against certain SARS-CoV-2 Omicron subvariants.
Hazard description
New safety information - Product safety - COVID
Product
Product name
EVUSHELD (tixagevimab and cilgavimab for injection)
Reference
ID
RA-72094